Franklin Resources Inc Verastem, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.39 - $0.71 $728 - $1,325	1,867 Added 1.73%	109,558 $46,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $851 - $10,334	926 Added 0.87%	107,691 $92,000
Q2 2022 Aug 11, 2022	SELL	$1.02 - $1.83 $52,980 - $95,053	-51,942 Reduced 32.73%	106,765 $124,000
Q4 2021 Feb 11, 2022	SELL	$2.05 - $3.2 $805 - $1,257	-393 Reduced 0.25%	158,707 $325,000
Q3 2021 Nov 12, 2021	BUY	$2.54 - $4.07 $404,114 - $647,537	159,100 New	159,100 $490,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.